Spicer, J., Wang, C., Tanaka, F., Chen, K., Ito, H., Liberman, M., Chen, Q., Girard, N., Lu, S., Provencio, M., Mitsudomi, T., Awad, M., Felip, E., Swanson, S., Forde, P., Cai, J., Mahmood, J., Hu, N., Tran, P., & Broderick, S. (n.d.). event-free survival (EFS) with neoadjuvant nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) versus chemo by surgical outcomes in resectable non-small cell lung cancer (NSCLC) from CheckMate 816. Lung cancer, 178, S26–S27. http://access.bl.uk/ark:/81055/vdc_100184747479.0x000053